Login / Signup

Effects of cabergoline therapy on serum IGF-1 concentrations in prolactinoma patients.

Pedro IglesiasCarles VillabonaJuan J Díez
Published in: Pituitary (2020)
Keyphrases
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • prognostic factors
  • replacement therapy